Autolus Therapeutics plc
جودة البيانات: 100%
AUTL
NASDAQ
Manufacturing
Chemicals
KWD 1.45
▼
KWD 0.03
(-2.03%)
6 months return
—
Momentum
Neutral
ROE
-93.98%
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)644.94%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-93.98%
أقل من متوسط القطاع (-54.68%)
ROIC-34.70%
Net Margin-381.40%
Op. Margin-358.87%
الأمان
Debt / Equity
N/A
Current Ratio6.19
Interest Coverage-7.38
التقييم
PE (TTM|NTM)
-1.37 | -2.09
أعلى من متوسط القطاع (-1.50)
P/B Ratio1.48
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -302.61 M
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
10 محللين
Buy
+506.2%
upside to target
الحالي
KWD 1.45
Consensus Target
KWD 8.79
KWD 5.00
أدنى
KWD 13.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-2.09
ربحية السهم المستقبلية
-KWD 0.71
الإيرادات المقدّرة
198.41 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.26
·
Rev Est: 26.13 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.26 | -KWD 0.18 | -KWD 0.30 | -KWD 0.34 | — | — |
| Estimate | -KWD 0.25 | -KWD 0.23 | -KWD 0.23 | -KWD 0.27 | -KWD 0.26 | -KWD 0.25 |
| المفاجأة | -4.19% | +23.37% | -32.84% | -28.00% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | 644.94% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -93.98% · Net Margin: -381.40%
Profitability
ROE: -93.98% · Net Margin: -381.40%| Revenue (TTM) | 75.39 M | Net Income (TTM) | -287.53 M |
| ROE | -93.98% | ROA | -41.58% |
| Gross Margin | N/A | Operating Margin | -358.87% |
| Net Margin | -381.40% | Free Cash Flow (TTM) | -302.61 M |
| ROIC | -34.70% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 6.19
Safety
D/E: N/A · Current: 6.19| Debt / Equity | N/A | Current Ratio | 6.19 |
| Interest Coverage | -7.38 | Asset Turnover | 0.11 |
| Working Capital | 431.51 M | Tangible Book Value | 245.17 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1.37 · EV/EBITDA: N/A
Valuation
P/E: -1.37 · EV/EBITDA: N/A| P/E Ratio | -1.37 | Forward P/E | -2.09 |
| P/B Ratio | 1.48 | P/S Ratio | 5.22 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.99 | Fwd Earnings Yield | N/A |
| FCF Yield | -76.83% | ||
| Market Cap | 393.89 M | Enterprise Value | 307.77 M |
Per Share
EPS: -1.08 · FCF/Share: -1.14
Per Share
EPS: -1.08 · FCF/Share: -1.14| EPS (Diluted TTM) | -1.08 | Revenue / Share | 0.28 |
| FCF / Share | -1.14 | OCF / Share | -1.07 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 105.25% · CapEx/Rev: 25.26%
Efficiency
FCF Conv: 105.25% · CapEx/Rev: 25.26%| CapEx / Revenue | 25.26% | FCF Conversion | 105.25% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75.39 M | 10.12 M | — | — | — |
| Net Income | -287.53 M | -220.66 M | -208.38 M | -148.84 M | -142.10 M |
| EPS (Diluted) | -1.08 | -0.86 | -1.20 | -1.57 | -1.97 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -270.54 M | -241.43 M | -179.70 M | -168.05 M | -165.00 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 117.69 M | 138.44 M | 130.48 M | 141.99 M | 134.79 M |
| SG&A Expenses | 131.87 M | 101.09 M | — | — | — |
| D&A | 8.30 M | 7.55 M | 6.57 M | 7.42 M | 8.46 M |
| Interest Expense | 36.67 M | 9.29 M | 45.07 M | 8.91 M | 1.11 M |
| Income Tax | 1.97 M | 1.53 M | -19,500.0 | -24.37 M | -23.89 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 589.07 M | 782.73 M | 375.38 M | 490.27 M | 405.56 M |
| Total Liabilities | 410.94 M | 355.40 M | 263.91 M | 191.60 M | 92.24 M |
| Shareholders' Equity | 178.13 M | 427.33 M | 111.47 M | 298.67 M | 313.32 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 104.13 M | 227.38 M | 239.57 M | 382.44 M | — |
| Current Assets | 435.92 M | 660.93 M | 275.30 M | 425.77 M | 346.95 M |
| Current Liabilities | 73.44 M | 60.74 M | 44.74 M | 46.37 M | 28.55 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.4 | -1.5 |
| P/B | 1.5 | 1.6 |
| ROE % | -94.0 | -54.7 |
| Net Margin % | -381.4 | -41.5 |
| Rev Growth 5Y % | — | 1.7 |
| D/E | — | 0.3 |
ETFs Holding This Stock
ETFs Holding This Stock
{"event":"ticker_viewed","properties":{"ticker":"AUTL","listing_kind":"stock","pathname":"/stocks/autl","exchange":"NASDAQ","country":"US"}}